Lyon: Inland CXOs and innovative drugs perform well. Adjusted target price for pharmaceutical stocks (table)

Lyon released a research report stating that they have reviewed the performance of several mainland pharmaceutical outsourcing (CXO) companies, traditional Chinese medicine companies, innovative drug companies, and medical service companies in the second half of last year and the fourth quarter. Overall, mainland CXO and innovative drug companies performed well, traditional Chinese medicine companies remained stable, while medical service companies need time to recover.